Engineered HC–LC interfaces direct correct chain pairing, enabling high-purity multispecific antibodies

Adimab's developability toolkit embeds predictive assays early in selection to accelerate clinical progress.

Synthetic, yeast-based HCAb platform enables rapid discovery of developable binders for complex multispecifics.

Highly developable soluble T cell receptors (TCRs) with high target affinities discovered from large yeast libraries

Atlas links 15+ years of antibody discovery data across 1,431 programs to power machine learning prediction and natural language querying

A case study describing how Adimab's platform translated HLA-G–specific leads into an antibody now in clinical trials